Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Intervalo de año de publicación
1.
Br J Pharmacol ; 146(5): 723-31, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16151439

RESUMEN

1 We investigated the single vs the combined long-term inhibition of Na(+)-H(+) exchanger-1 (NHE-1) and ACE in rats with congestive heart failure induced by myocardial infarction (MI). 2 Rats with MI were randomized to receive either placebo, cariporide (3000 p.p.m. via chow), ramipril (1 mg kg(-1) day(-1) via drinking water) or their combination for 18 weeks starting on day 3 after surgery. 3 Cardiac morphology and function was assessed by echocardiography and by means of a 2.0 F conductance catheter to determine left ventricular (LV) pressure volume relationships. 4 MI for 18 weeks resulted in an increase in LV end-diastolic diameter (LVDed) in the placebo-treated group when compared to sham (placebo: 1.1+/-0.04 cm; sham: 0.86+/-0.01; P<0.05). Combined inhibition of NHE-1 and ACE, but not the monotherapies, significantly reduced LVDed (1.02+/-0.02 cm). 5 Preload recruitable stroke work (PRSW), dp/dt(max) (parameter of systolic function) and end-diastolic pressure volume relationship (EDPVR, diastolic function) were significantly impaired in placebo-treated MI group (PRSW: 39+/-7 mmHg; dp/dt(max): 5185+/-363 mmHg s(-1); EDPVR: 0.042+/-0.001 mmHg microl(-1); all P<0.05). Cariporide treatment significantly improved PRSW (64+/-7 mmHg), dp/dt(max) (8077+/-525 mmHg s(-1)) and EDPVR (0.026+/-0.014 mmHg microl(-1)), and reduced cardiac hypertrophy in rats with MI. Combined inhibition of NHE-1 and ACE had even a more pronounced effect on PRSW (72+/-5 mmHg) and EDPVR (0.026+/-0.014 mmHg microl(-1)), as well as cardiac hypertrophy that, however, did not reach statistical significance compared to cariporide treatment alone. 6 The NHE-1 inhibitor cariporide significantly improved LV remodeling and function in rats with congestive heart failure induced by MI. The effect of cariporide was comparable or tended to be stronger (e.g. systolic function) compared to ramipril. Combined treatment with cariporide and ramipril tended to be more effective on LV remodeling in rats with heart failure than the single treatments. Thus, inhibition of the NHE-1 may be a promising novel therapeutic approach for the treatment of congestive heart failure.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Insuficiencia Cardíaca/metabolismo , Infarto del Miocardio/complicaciones , Peptidil-Dipeptidasa A/efectos de los fármacos , Ramipril/farmacología , Intercambiadores de Sodio-Hidrógeno/antagonistas & inhibidores , Animales , Guanidinas/farmacología , Corazón/efectos de los fármacos , Insuficiencia Cardíaca/complicaciones , Insuficiencia Cardíaca/enzimología , Pulmón/efectos de los fármacos , Masculino , Tamaño de los Órganos , Ratas , Ratas Sprague-Dawley , Sulfonas/farmacología
2.
J Cell Sci ; 117(Pt 12): 2611-22, 2004 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-15159456

RESUMEN

Basement membranes generally determine different tissue compartments in complex organs, such as skin, playing not only an important structural but also a regulatory role. We have previously demonstrated the formation of a regular basement membrane in organotypic three-dimensional (3D)-cocultures of human skin keratinocytes and fibroblasts by indirect immunofluorescence and transmission electron microscopy. In this assembly process, cross-linking of type IV collagen and the laminin gamma1 chain by nidogen is considered a crucial step. For a functional proof, we have now competitively inhibited nidogen binding to laminin in 3D-cocultures with a recombinant laminin gamma1 fragment (gamma1III3-5 module) spanning this binding site. Repeated treatment abolished the deposition of nidogen at the epithelial-matrix interface but also greatly perturbed the presence of other matrix constituents such as laminin and perlecan. This effect persisted over the entire observation period of 10 to 21 days. In contrast, some components of the basement membrane zone were only moderately affected, with the laminin-5 isoform (gamma2 chain), type IV collagen and integrin alpha6ss4 still showing a distinct staining at their regular position, when seen by light microscopy. Furthermore, epidermal morphology and differentiation remained largely normal as indicated by the regular location of keratins K1/K10 and also of late differentiation markers. Ultrastructural examination demonstrated that the gamma1 fragment completely suppressed any formation of basement membrane structures (lamina densa) and also of hemidesmosomal adhesion complexes. As a consequence of hemidesmosome deficiency, keratin filament bundles were not attached to the ventral basal cell aspect. These findings were further substantiated by immuno-electron microscopy, revealing either loss or drastic reduction and dislocation of basement membrane and hemidesmosomal components. Taken together, in this simplified human skin model (representing a 'closed system') a functional link has been demonstrated between compound structures of the extra- and intracellular space at the junctional zone providing a basis to interfere at distinct points and in a controlled fashion.


Asunto(s)
Membrana Basal/metabolismo , Laminina/metabolismo , Glicoproteínas de Membrana/metabolismo , Piel/citología , Membrana Basal/ultraestructura , Sitios de Unión , Proteínas Portadoras/efectos de los fármacos , Proteínas Portadoras/metabolismo , Proteínas Portadoras/ultraestructura , Diferenciación Celular , Células Cultivadas , Técnicas de Cocultivo , Colágeno Tipo IV/efectos de los fármacos , Colágeno Tipo IV/metabolismo , Colágeno Tipo IV/ultraestructura , Reactivos de Enlaces Cruzados/metabolismo , Relación Dosis-Respuesta a Droga , Factores Eucarióticos de Iniciación , Matriz Extracelular/química , Técnica del Anticuerpo Fluorescente Indirecta , Hemidesmosomas/ultraestructura , Proteoglicanos de Heparán Sulfato/metabolismo , Humanos , Integrina alfa6beta4/efectos de los fármacos , Integrina alfa6beta4/metabolismo , Proteínas de Filamentos Intermediarios/efectos de los fármacos , Proteínas de Filamentos Intermediarios/metabolismo , Proteínas de Filamentos Intermediarios/ultraestructura , Queratina-1 , Queratina-10 , Queratinocitos/metabolismo , Queratinas/metabolismo , Queratinas/ultraestructura , Laminina/efectos de los fármacos , Laminina/genética , Laminina/farmacología , Técnicas de Cultivo de Órganos , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA